Eisai Q3 FY2025 slides reveal 109% growth in LEQEMBI sales, strategic oncology investments Personal Finance February 9, 2026 Eisai Q3 FY2025 slides reveal 109% growth in LEQEMBI sales, strategic oncology investments
